Panelists discuss how chronic graft-vs-host disease (cGVHD) results from complex biological mechanisms involving inflammation, loss of peripheral tolerance, and fibrotic pathways affecting multiple ...

Primary hepatitis C virus (HCV) care cascade outcomes are low among children with HCV, with racial and ethnic disparities ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious ...

China, with its enabling climate for innovative drugs, and extensive expertise and increasing opening-up in clinical trials, will be an important force in helping tackle the global challenge of ...

The session titled “Defeating Cancer by Curing Infections” at European Society of Clinical Microbiology and Infectious ...

Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced eight abstracts have ...

Advancements Critical tests such as HIV Early Infant Diagnosis, Hepatitis E, Troponin T, D-Dimer, and Prostate Specific Antigen have been rolled out in remote labs from Opuwo and Okahao to Khorixas ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

The global molecular diagnostic market size is projected to increase from USD 368.53 million in 2025 and is estimated to be ...

JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, announced the preliminary results of a ...

The Namibia Institute of Pathology (NIP) is significantly upgrading its diagnostic testing capabilities through a comprehensive Equipment Replacement Plan (ERP). This initiative is a core element of ...